Leading Financial Service Provider in India | Canara Bank Securities Ltd

Bal Pharma Ltd.

May 29, 04:01 BSE 90.25 ( -6.61 -6.82%)

Volume12072

Prev. Close
96.86

Open Price
91.51

Today's Low / High

89.00 94.60

Bid. Price (Qty.)0.00 (0)

Offer Price (Qty.)
0.00 (0)

52 Wk Low / High

59.69 112.97

May 29, 03:59 NSE 90.12( -6.31 -6.54%)

Volume73218

Prev. Close
96.43

Open Price
95.99

Today's Low / High

88.00 96.97

Bid Price (Qty.)0.00 (0)

Offer Price (Qty.)
90.12 (1062)

52 Wk Low / High

60.00 111.18

Market Cap. ( ₹ in Cr. )	143.48	P/BV	1.79	Book Value ( ₹ )	50.32
52 Week High/Low ( ₹ )	111/60	FV/ML	10/1	P/E(X)	22.70
Book Closure	25/09/2025	EPS ( ₹ )	3.97	Div Yield (%)	1.33

(₹ in Crs.)

Particulars	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	PR	AR	AR	AR	AR
FaceValue	10.00	10.00	10.00	10.00	10.00
No. of Equity Shares (in Lacs)	159.21	159.21	158.04	156.90	148.24

EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	15.92	15.92	15.80	15.69	14.82
Total Share Capital	15.92	15.92	15.80	15.69	14.82

Reserves and Surplus	66.31	61.50	53.49	48.10	42.87
Total Reserves and Surplus	66.31	61.50	53.49	48.10	42.87
Money Received Against Share Warrants	0.00	0.00	0.00	0.00	0.94
Total Shareholders Funds	82.23	77.42	69.29	63.79	58.63
Minority Interest	0.03	-0.01	-0.03	-0.09	-0.13

NON-CURRENT LIABILITIES
Long Term Borrowings	31.88	31.40	36.35	30.52	27.01
Deferred Tax Liabilities [Net]	0.00	0.00	3.96	2.87	0.60
Other Long Term Liabilities	5.97	1.74	1.83	1.68	4.08
Long Term Provisions	6.20	5.64	5.09	5.07	4.69
Total Non-Current Liabilities	44.06	38.79	47.22	40.14	36.40

CURRENT LIABILITIES
Short Term Borrowings	127.63	118.98	103.25	100.48	70.75
Trade Payables	88.97	81.69	77.46	78.92	65.56
Other Current Liabilities	31.86	17.67	21.38	29.30	28.60
Short Term Provisions	0.77	1.17	0.95	0.64	0.73
Total Current Liabilities	249.23	219.50	203.04	209.33	165.64

Total Capital And Liabilities	375.54	335.69	319.53	313.17	260.53

ASSETS
NON-CURRENT ASSETS
Tangible Assets	76.75	70.99	61.61	62.18	55.57
Intangible Assets	13.42	12.00	11.38	10.46	7.99
Capital Work-In-Progress	7.42	2.79	0.47	0.00	1.61
Fixed Assets	97.60	85.77	73.46	72.64	65.18
Goodwill On Consolidation	3.83	3.83	3.83	3.83	3.83
Deferred Tax Assets [Net]	0.80	0.41	2.41	2.17	0.00
Long Term Loans And Advances	0.00	0.00	0.12	0.10	0.40
Other Non-Current Assets	11.08	10.81	5.56	6.29	6.56
Total Non-Current Assets	113.31	100.82	85.38	85.02	75.96


CURRENT ASSETS
Current Investments	2.08	2.47	6.76	0.00	0.00
Inventories	116.36	103.02	87.81	98.01	74.40
Trade Receivables	93.63	92.44	99.62	93.98	75.31
Cash And Cash Equivalents	3.47	8.05	13.29	7.61	5.39
Short Term Loans And Advances	0.00	1.13	1.37	0.96	2.37
OtherCurrentAssets	46.70	27.76	25.30	27.60	27.10
Total Current Assets	262.23	234.87	234.15	228.16	184.57

Total Assets	375.54	335.69	319.53	313.17	260.53

OTHER INFORMATION

CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	0.00	17.10	16.96	0.00	0.00

BONUS DETAILS
Bonus Equity Share Capital	0.00	3.04	3.04	3.04	3.04

Particulars	Mar 26
Months	12
Source Of Info (AR = Annual Report, PR = Press Release)	PR
FaceValue	10.00
No. of Equity Shares (in Lacs)	159.21

EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	15.92
Total Share Capital	15.92
Reserves and Surplus	66.31
Total Reserves and Surplus	66.31
Money Received Against Share Warrants	0.00
Total Shareholders Funds	82.23
Minority Interest	0.03
NON-CURRENT LIABILITIES
Long Term Borrowings	31.88
Deferred Tax Liabilities [Net]	0.00
Other Long Term Liabilities	5.97
Long Term Provisions	6.20
Total Non-Current Liabilities	44.06
CURRENT LIABILITIES
Short Term Borrowings	127.63
Trade Payables	88.97
Other Current Liabilities	31.86
Short Term Provisions	0.77
Total Current Liabilities	249.23
Total Capital And Liabilities	375.54
ASSETS
NON-CURRENT ASSETS
Tangible Assets	76.75
Intangible Assets	13.42
Capital Work-In-Progress	7.42
Fixed Assets	97.60
Goodwill On Consolidation	3.83
Deferred Tax Assets [Net]	0.80
Long Term Loans And Advances	0.00
Other Non-Current Assets	11.08
Total Non-Current Assets	113.31
CURRENT ASSETS
Current Investments	2.08
Inventories	116.36
Trade Receivables	93.63
Cash And Cash Equivalents	3.47
Short Term Loans And Advances	0.00
OtherCurrentAssets	46.70
Total Current Assets	262.23
Total Assets	375.54
OTHER INFORMATION
CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	0.00
BONUS DETAILS
Bonus Equity Share Capital	0.00

Markets

Balance Sheet

BALANCE SHEET

Bal Pharma Ltd.